Workflow
Veracyte: Q2 Earnings Brings My Position Out Of Mothballs

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been nearly five years since my last Veracyte (NASDAQ: VCYT ) article , where I applauded the company’s efforts to navigate the first year of the pandemic. At that time, I had just booked some profitHe is the leader of the investing group Compound ...